They Said No

Every founder who rejects an acquisition offer has a reason. The reasons change. The outcome rarely does.

Cedric Atkinson

A colleague of mine attended an executive education session at Harvard Business School. The subject was corporate exits. Halfway through a case study on acquisitions, the professor paused the discussion and said something that was not in the materials.

"Your first offer is probably your best offer. Take it."

She told me this over dinner, years later. We were discussing a company she had been advising for some time. A company that had received three acquisition offers over four years and rejected every one of them.

The three calls

The company made a physical consumer product. Manufactured overseas, shipped in boxes, sold through a mix of direct-to-consumer and retail channels. During the pandemic, the category surged. Revenue climbed past twenty million dollars. Gross margins ran above sixty percent. By conventional measures, the business was working well.

The product had distribution in major retail chains. The marketing operation was efficient, returning eight dollars for every one invested. The team was small, overhead low. The pandemic had been an accelerant, not the foundation. The business existed before the surge.

That is what the founder believed. It was a reasonable description of the past. It was not an accurate forecast of the future.

An acquirer called. The offer was roughly twice the company's annual revenue. A clean exit at a fair multiple. The founder said no.

The reasoning was straightforward. Revenue was climbing. Margins were strong. The product had a growing customer base and expanding retail distribution. Selling now meant walking away at the start of what looked like a run.

Revenue peaked. Then it turned.

The pandemic-era demand that had lifted the category began normalizing. A major retail partner dropped the product line entirely, taking millions in annual revenue with it. Marketing efficiency deteriorated. The returns that had once been exceptional stopped performing at anywhere near that level. The founder cut marketing spend to preserve cash.

The decline was not dramatic at first. Revenue fell roughly a quarter in the year after peak. The founder framed it as normalization. Post-pandemic correction. The category adjusting. He was right that the category was adjusting. He was wrong about where the adjustment would stop.

He restored the marketing budget. But the market had changed while the spending was off.

During the downturn, the company had run constant promotions. Twenty to forty percent off, cycling through the calendar. The promotions maintained sales velocity. They also conditioned the customer base. Shoppers who had once paid full price learned to wait for the next discount. When the promotion ended, demand dropped. When the next one launched, demand returned, but at compressed margins. The company was no longer selling a product at a price. It was selling a discount on a product. Removing the discount meant removing the demand.

The phone rang again. A second offer. Lower in absolute dollars, but more generous relative to the company's declining revenue. The founder said no.

Between the second and third calls, the distress became structural. Monthly cash flow went negative. The company began stretching payables, leaning on supplier credit to cover operating costs. Working capital tightened. Inventory worth several months of declining sales sat in a warehouse. A co-founder departed, triggering a buyout obligation the company did not have the cash to fund.

A third offer arrived. Comparable to the second. The founder's response, as it was relayed to me: "It's not a problem. These are peaks and valleys. I can get back to where I was."

He could not.

Revenue fell by three-quarters from its peak over three years. New tariffs on imported materials pushed production costs higher while revenue continued to fall. The founder proposed cutting prices. Lower prices would drive volume. Volume would restore revenue. The reasoning was circular. Price was not the problem. Demand had moved.

The acquirer who had been turned away built a competing product. Not a knock-off. A comparable product in the same category, sold through the same retail channels, at a lower price. The company holds patents on its design. Enforcing them would cost more than the patents are worth. When the patent holder cannot afford litigation, the patent provides paper, not protection.

In late 2025, an M&A advisor assessed the business. His conclusion: a deal at roughly one-tenth of the original offer might be viable. The number the founder had rejected three times was now a number the company could not reach.

The same judgment that rejected the first offer at the peak is the same judgment now forecasting a recovery from the bottom. The founder has not changed his assessment. He has never changed his assessment. That is the point.

The public record

The specifics change. The pattern does not.

In May 2017, Target held acquisition discussions with Casper, the direct-to-consumer mattress company. Casper was three years old. It had sold roughly $200 million worth of mattresses the year before, shipping them compressed in boxes to doorsteps across the country. Target reportedly offered approximately $1 billion.1

The talks broke down. Target invested $75 million in Casper's next funding round instead.2

Two years later, Casper raised another $100 million at a $1.1 billion valuation.3 The company had crossed the unicorn threshold. The belief appeared justified. One billion had not been enough. The private market said they were worth more than what Target had put on the table.

Then Casper went public.

The company had originally priced its IPO range at $17 to $19 per share. The night before trading began, the range was cut to $12.4 On February 6, 2020, Casper opened on the New York Stock Exchange with a market capitalization of $476 million. Less than half the private valuation from eleven months earlier. Less than half the price that had been on the table in 2017.

The stock never recovered. It drifted lower for nearly two years. By November 2021, shares traded at $3.55.

A private equity firm, Durational Capital Management, took the company private in January 2022 for $6.90 per share. Total deal value: approximately $286 million.5 In October 2024, Casper was sold again, to Carpenter Co., the world's largest manufacturer of polyurethane foams. The price was not disclosed.6

Casper had raised approximately $340 million in venture capital across five private funding rounds.7 The company sold for less than the capital that had been invested in it. The billion-dollar offer that was not enough in 2017 became a number the company would never reach again.

Casper Sleep: the staircase down Target acquisition talks (2017): ~$1B
Peak private valuation (2019): $1.1B
IPO market cap (Feb 2020): $476M
Take-private deal (Jan 2022): ~$286M
Total capital raised (2014-2019): ~$340M
The exit did not return the invested capital. Sources: Recode, Bloomberg, CNBC, BusinessWire.

A company that raised a third of a billion dollars to reimagine how people buy mattresses ended its run as a subsidiary of the company that makes the foam inside them.

The gap

In both cases, the stated reason for not taking the deal was different. The consumer products founder pointed to peaks and valleys. Casper's leadership pointed to the next round, the next valuation, the IPO that would prove them right. Different words, same underlying belief: the next number will be higher than this one.

Markets do not share this belief. Markets price trajectory.

When an acquirer makes an offer, the number reflects a forward-looking assessment. Growth rate, competitive position, market timing, integration value. The offer is not a grade on what the company has accomplished. It is a bet on where the company is going. When the trajectory changes, the offer changes with it. Not gradually. In steps.

Founders price memory.

The anchor is always the peak. The highest revenue quarter. The largest customer win. The moment when everything was working. This is not irrational in the conventional sense. The peak represents real achievement. But achievement and trajectory are not the same measurement. A founder remembers twenty million in revenue. The market sees the direction the number is heading.

Daniel Kahneman and Amos Tversky documented this asymmetry in 1979. People evaluate outcomes relative to a reference point, and losses from that reference point are felt roughly twice as intensely as equivalent gains.8 Selling a company below its perceived peak value registers as a loss. Holding it while the value declines does not register the same way, because the loss is unrealized. It remains theoretical until the founder sells or shuts down. The founders who let a billion-dollar offer pass are not comparing one billion to the $286 million the company will eventually sell for. They are comparing one billion to the number they believe the IPO will produce.

Kahneman and his colleagues identified a related mechanism: people consistently ascribe more value to things they own than to identical things they do not own.9 A coffee mug, a lottery ticket, a company. Ownership inflates perceived value. The founder's price includes the identity, the years, the story of how the business was built. The market's price includes none of those things. The market prices the trajectory.

This creates a specific and observable pattern. Offers arrive when the company is performing well, because acquirers want to buy growing businesses. The offers are rejected because strong performance creates the conviction that more performance is coming. By the time the trajectory bends and the founder begins to reconsider, the market has already repriced. The founder's anchor stays fixed at the peak. The market's price updates continuously.

The gap between those two prices is where the value disappears. The founder holds, because selling feels like losing. The market reprices, because the numbers have changed. Each quarter of declining revenue widens the distance. Each rejected offer makes the next one lower. The founder is measuring what the company meant. The market is measuring what the company will do next.

They were measuring different things.

The founders in these stories were not reckless. In every case, the conviction that led to the rejection was the same conviction that had built the company. Belief in the product. Belief in the trajectory. Belief that the best number was still coming. That conviction is the reason the company existed at all. Without it, there is no product, no revenue, no offer to reject.

The numbers that bring the offer are the same numbers that make it feel too early to sell.

The professor at Harvard said it as a throwaway. Your first offer is probably your best offer. My colleague carried that line for years, watching it come true three times with the same company, while the founder explained each time why this moment was different from the last. He is still explaining.

They said no because they were still inside the belief. And you cannot check a belief from inside it.

New pieces when they're ready. Nothing else.

Sources

  1. Jason Del Rey, "Target held serious acquisition discussions with Casper at approximately $1 billion," Recode/Vox, May 19, 2017. Based on multiple sources familiar with the negotiations. Neither party confirmed the figure publicly.
  2. Jason Del Rey, "Target invests $75 million in Casper as part of a $170 million Series C round," Recode/Vox, May 25, 2017. The investment followed the breakdown of acquisition discussions.
  3. Casper valued at $1.1 billion with $100 million Series D round, March 2019. Reported by Bloomberg and TechCrunch. Total private capital raised across five rounds: approximately $340 million.
  4. Casper IPO priced at $12 per share, February 5, 2020. Original target range of $17 to $19 per share was reduced to $12-$13 earlier that day. Market capitalization at IPO: approximately $476 million. CNBC, Bloomberg.
  5. Durational Capital Management acquisition of Casper Sleep announced November 15, 2021 at $6.90 per share (approximately $286 million). Deal closed January 24, 2022. BusinessWire.
  6. Carpenter Co. acquisition of Casper Sleep announced October 29, 2024. Casper operates as a subsidiary. Financial terms not disclosed. BedTimes Magazine, Retail Dive.
  7. Casper total venture capital raised: approximately $340 million across seed, Series A, B, C, and D rounds (2014-2019). Crunchbase, PitchBook.
  8. Daniel Kahneman and Amos Tversky, "Prospect Theory: An Analysis of Decision under Risk," Econometrica 47, no. 2 (March 1979): 263-292.
  9. Daniel Kahneman, Jack L. Knetsch, and Richard H. Thaler, "Experimental Tests of the Endowment Effect and the Coase Theorem," Journal of Political Economy 98, no. 6 (December 1990): 1325-1348.